论文部分内容阅读
目的观察低分子肝素钙、地尔硫卓治疗不稳定型心绞痛的临床疗效。方法随机将治疗的78例不稳定型心绞痛患者分为治疗组40例,对照组38例。对照组给予常规治疗,治疗组给予低分子肝素钙5000 U,皮下注射1次/12 h,地尔硫卓50 mg加入5%葡萄糖250 ml静滴,1次/d,观察治疗14 d后疗效。结果治疗组疗效明显优于对照组(P<0.01),且无明显不良反应。结论低分子肝素钙联合地尔硫卓治疗不稳定型心绞痛可靠,具有良好的安全性。
Objective To observe the clinical effects of low molecular weight heparin and diltiazem in the treatment of unstable angina pectoris. Methods A total of 78 patients with unstable angina pectoris were randomly divided into treatment group (40 cases) and control group (38 cases). The control group was given routine treatment. The treatment group received low molecular weight heparin 5000 U, subcutaneous injection 1/12 h, diltiazem 50 mg 5% glucose 250 ml intravenous infusion, once / d, observed after 14 days of treatment. Results The treatment group was significantly better than the control group (P <0.01), and no significant adverse reactions. Conclusion Low molecular weight heparin combined with diltiazem is safe and reliable for the treatment of unstable angina pectoris.